Natural History Study of Excess Androgens in CAH and FMPP

Natural History Study of Patients With Excess Androgen

Recruiting Observational Study
Congenital Adrenal Hyperplasia (CAH) Familial Male-Limited Precocious Puberty (FMPP)
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
1 Day – 99
Sex
Any
Study type
Observational
Participants needed
3,000 (estimated)
Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) · NIH
Who this trial is looking for

This trial is looking for patients with genetic conditions that cause too much androgen, like congenital adrenal hyperplasia (CAH) or familial male-limited precocious puberty (FMPP). Participants will provide medical history, undergo physical exams, and have blood tests to help researchers understand the effects of excess androgen.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am a male aged 0 to 99 with known or suspected FMPP
  • I have been diagnosed with CAH of any type
  • I have excess androgen of unknown cause
  • I am a relative of a patient in this study

You may not be able to join if

  • I am a female with isolated polycystic ovary syndrome
  • I have significant non-endocrine medical conditions
  • I am female and pregnant at the time of initial enrollment

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial
This study will evaluate and gather information in patients with genetic causes of too much androgen (male-like hormone) in order to better understand the effects of too much androgen and describe problems associated with it. Too much androgen in childhood, if untreated, results in rapid growth and early puberty with early cessation of growth and short stature in adulthood. Too much androgen in ad…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
* INCLUSION CRITERIA: 1. Males, ages 0 - 99 with known or suspected FMPP or 2. Patients (males and females, ages 0 - 99) with known or suspected (based on hormonal, clinical and/or genetic testing) CAH of any type. 3. Patients with excess androgen of unknown etiology or 4. Relatives of pati…
Contacts

Deborah P Merke, M.D.

(301) 496-0718

dmerke@nih.gov

CONTACT